Medtronic Pain Interventions’ Post

Our devices are trusted by leading institutions worldwide! We are extremely thankful to the institutions that have trusted in our tVNS® devices and have found groundbeaking results in research for using our device to alleviate symptoms of various conditions. For over two decades, our dedication to pioneering innovation has positioned us as leaders in non-invasive vagus nerve stimulation. Our extensive research and development, supported by robust clinical trials, guarantee the effectiveness, safety, and reliability of our devices! With Class IIa medical device approval under the EU-MDR, we provide scientifically validated solutions in a market saturated with unverified alternatives. Since the launch of the Cerbomed Nemos device, we've maintained our leadership in non-invasive vagus nerve technology, preferred by healthcare professionals and researchers worldwide for its unparalleled safety, reliability, and precision! Click the link in our bio to find out more about how our devices are revolutionising the medical industry! #tvns #vagusnerve #vagusnervestimulation #noninvasivetreatment #anxietytreatment

Ophthopedia Update:VIDEO: OmniVu IOL system shows stability, good refractive predictability: SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Daniel H. Chang, MD, discusses the 12-month results of the first-in-human clinical trial of the OmniVu IOL system from Atia Vision. The trial assessed the IOL’s impact on both monocular and binocular vision in 21 eyes of 16 patients in India and the Republic of Georgia. Binocular uncorrected visual acuity was at distance 20/16, at intermediate approximately 20/20 and at near about 20/25. “[It is] a lens with great distance, intermediate and near vision, great range of vision, good contrast and — the

Exciting news today as Biosense Webster receives European CE mark approval for our VARIPULSE™ Platform, marking a significant step forward in treating cardiac arrhythmia with pulsed field ablation (PFA) technology. With estimates suggesting that by 2050, Europe will have the greatest increase in Atrial Fibrillation compared to other regions globally, this milestone not only signifies our commitment to innovation in cardiac care but also positions us here in Europe at the forefront of solving some of the most pressing challenges in cardiac care. Our focus now is working alongside physicians and healthcare providers, together with our leading clinical teams throughout the region to bring this technology to all those patients who can benefit. https://lnkd.in/edYARrJz #myCompany #CardiacCare #JNJMedTechProud #VARIPULSE #PulsedFieldAblation

A new era in SCS technology is here! We celebrate those physicians who performed the first commercial implants of the Inceptiv™ spinal cord stimulator with closed-loop technology. Congratulations Dr. Georgios Matis, Cologne Univ. Hospital, Germany; Dr. Dirk Rasche, UKSH Lübeck, Germany; Prof. Paul Murphy, St. Vincent's Private Hospital, Ireland; Dr. Iris Smet and team, Vitaz Hospital, Belgium; Dr. Ash Gulve, James Cook Hospital, UK. This is a big milestone as we celebrate the use of the most advanced SCS system with a closed-loop feature that senses each person’s unique biological signals and adjusts stimulation moment to moment, as needed, to keep therapy in harmony with the motions of daily life†. Inceptiv™ is only approved in the EU and Japan. †Sensing signals may not be measurable in all cases. #neuromodulation #MedtronicPainInterventions #MedtronicSCS #Inceptiv #closedloopSCS #SpinalCordStimulation https://bit.ly/3Sw9qFz

#HeartFailureAwarenessWeek ❤️ I would highly recommend to my network to check out the below companies in the Heart Failure space! V-Wave - With offices in Israel and the US, V-Wave is dedicated to developing the Ventura, Interatrial Shunt which is a novel, hourglass-shaped implantable device. The shunt is designed to enable shunting of blood across the interatrial septum. Procyrion, Inc. - Aortix is a percutaneous mechanical circulatory support (pMCS) device designed to treat heart failure patients who are too sick for medication alone. Alleviant Medical - The device is designed to create a connection between the left and right atrial chambers of the heart through a single procedure without leaving a permanent implant behind. Carmat - Aeson is an active implantable device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The device is electro-hydraulically driven with a shape close to that of a human heart. Impulse Dynamics - The Optimizer Smart Mini is a minimally invasive implantable device that treats patients experiencing moderate to severe CHF symptoms even after appropriate medical treatment. The device operates by delivering precisely timed electric pulses called cardiac contractility modulation therapy. #medtech #searchsmartergrowfaster #heartfailure

Automatic, objective, daily remote monitoring powers BIOTRONIK Neuro’s one-of-a-kind proactive care. What does that mean for SCS patients? Join us at #ASPN2024 for “Unparalleled Proactive Care: Clinical Evidence for Prospera™”. At this lunch symposium, we’ll explore the data driving BIOTRONIK Neuro’s spinal cord stimulation (SCS) innovation—the Prospera SCS System with Embrace One™. Register today: https://ow.ly/aGW450SpvBr #BIOTRONIKNeuro

Explore Opportunities in the Dynamic Pacemakers Market! The Pacemakers Market is projected to experience a growth of 3-4% by 2028, fueled by various factors such as the rising prevalence of cardiovascular diseases, increased demand for minimally invasive procedures, technological advancements in pacemaker technology, a growing aging population, and favorable reimbursement environments in key markets. 🌐 Key Market Players: Join industry leaders shaping the future! 🌟 Explore opportunities with companies at the forefront of innovation, including Boston Scientific, Cook Medical, GE HealthCare, ZOLL Medical Corporation, Medtronic, LivaNova, OSYPKA MEDICAL GmbH, BIOTRONIK, Lepu Medical Technology (Beijing) Co., Ltd., and Abbott. 💼 Connect with Our Expert: Looking to dive deeper into the Pacemakers Market or explore collaboration possibilities? Connect with our expert, t, Manoj Sahasrabu he Gunjan Tha ur Gaurav Si ha BA Ram Song ra Minal Ka ra Kalpesh J in MEHER PANJW NI Madhuri, and gain valuable insights. 🤝 #HealthcareInnovation #Pacemakers #CardiovascularHealth #MedicalTechnology #ConnectWithExperts #IndustryInsights #HealthTechRevolution #CardioCare #MedicalInnovation #FutureOfHealthcare #InvasiveProcedures #TechAdvancements #MarketGrowth #HeartHealth #HealthcareTrends #IndustryLeadership #ConnectAndCollaborate #PacemakersInsights #MedTechLeaders #GlobalHealthcare #InnovationHub #HealthcareAnalytics #CardiovascularTech #ExpertConnect #MarketForecast #DigitalHealthWave

More than just resolution

Please read the third instalment of Otsuka Medical Devices Co., Ltd.'s four-part series on innovation at OMD, introducing the group companies.

Explore Opportunities in the Dynamic Pacemakers Market! The Pacemakers Market is projected to experience a robust growth of 3-4% by 2028, fueled by various factors such as the rising prevalence of cardiovascular diseases, increased demand for minimally invasive procedures, technological advancements in pacemaker technology, a growing aging population, and favorable reimbursement environments in key markets. 🌐 Key Market Players: Join industry leaders shaping the future! 🌟 Explore opportunities with companies at the forefront of innovation, including Boston Scientific, Cook Medical, GE HealthCare, ZOLL Medical Corporation, Medtronic, LivaNova, OSYPKA MEDICAL GmbH, BIOTRONIK, Lepu Medical Technology (Beijing) Co., Ltd., and Abbott. #HealthcareInnovation #Pacemakers #CardiovascularHealth #MedicalTechnology #ConnectWithExperts #IndustryInsights #HealthTechRevolution #CardioCare #MedicalInnovation #FutureOfHealthcare #InvasiveProcedures #TechAdvancements #MarketGrowth #HeartHealth #HealthcareTrends #IndustryLeadership #ConnectAndCollaborate #PacemakersInsights #MedTechLeaders #GlobalHealthcare #InnovationHub #HealthcareAnalytics #CardiovascularTech #ExpertConnect #MarketForecast #DigitalHealthWave